BIOTINYLATED DRB SEQUENCE-SPECIFIC OLIGONUCLEOTIDES - COMPARISON TO SEROLOGIC HLA-DR TYPING OF ORGAN DONORS IN EUROTRANSPLANT

被引:133
作者
VERDUYN, W
DOXIADIS, IIN
ANHOLTS, J
DRABBELS, JJM
NAIPAL, A
DAMARO, J
PERSIJN, GG
GIPHART, MJ
SCHREUDER, GMT
机构
[1] LEIDEN UNIV HOSP,DEPT IMMUNOHEMATOL,BLDG 1 E3-Q,POB 9600,2300 RC LEIDEN,NETHERLANDS
[2] EUROTRANSPLANT FDN,LEIDEN,NETHERLANDS
[3] LEIDEN UNIV HOSP,BLOOD BANK,2333 AA LEIDEN,NETHERLANDS
关键词
D O I
10.1016/0198-8859(93)90143-O
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A novel HLA-DR typing method was applied using PCR-amplified fragments and biotin-labeled oligonucleotides (PCR-biotin-SSO). The PCR-biotin-SSO method can be used efficiently to perform HLA-DR typing for a large number of individuals when time is not the limiting factor. The reliability of HLA typing of cadaveric organ donors is of vital importance for organ exchange organizations such as ET. Due to lack of time, these typings are usually performed by the complement-dependent cytotoxicity. The individual donor center typings are immediately reported to ET, where the recipient 'selection procedure is started. DNA isolated from donor spleen material, sent to the ETRL for retyping purposes, was subjected to PCR-biotin-SSO typing. The results were compared with the serological HLA-DR typings as reported to ET. The analysis of 1052 donor samples for the broad DR1-DR10 antigens revealed a concordance rate of over 90% between the donor center and the ETRL. The majority of the discrepancies involved specificities of the HLA-DR5, DR6, and DR8 cross-reacting group, with DR6 as the predominant discordant specificity. The results indicate (a) that PCR-biotin-SSO is a reliable technique for DNA-based HLA-DR typing and (b) that HLA-DR serology is still a useful technique when time is limited, such as for cadaveric donor typing.
引用
收藏
页码:59 / 67
页数:9
相关论文
共 10 条
[1]   REPRODUCIBILITY OF HLA-A, B, AND DR TYPING USING PERIPHERAL-BLOOD SAMPLES - RESULTS OF RETYPING IN THE COLLABORATIVE CORNEAL TRANSPLANTATION STUDIES [J].
HOPKINS, KA ;
MAGUIRE, MG ;
FINK, NE ;
BIAS, WB .
HUMAN IMMUNOLOGY, 1992, 33 (02) :122-128
[2]  
Maniatis T, 1989, MOL CLONING
[3]   COMPARISON OF RFLP-DR-BETA AND SEROLOGICAL HLA-DR TYPING IN 1500 INDIVIDUALS [J].
MYTILINEOS, J ;
SCHERER, S ;
OPELZ, G .
TRANSPLANTATION, 1990, 50 (05) :870-873
[4]   SURVIVAL OF DNA HLA-DR TYPED AND MATCHED CADAVER KIDNEY-TRANSPLANTS [J].
OPELZ, G ;
MYTILINEOS, J ;
SCHERER, S ;
DUNCKLEY, H ;
TREJAUT, J ;
CHAPMAN, J ;
MIDDLETON, D ;
SAVAGE, D ;
FISCHER, O ;
BIGNON, JD ;
BENSA, JC ;
ALBERT, E ;
NOREEN, H .
LANCET, 1991, 338 (8765) :461-463
[5]  
SCHREUDER GMT, 1986, TISSUE ANTIGENS, V27, P131
[6]  
SCHREUDER GMT, 1984, HISTOCOMPATIBILITY T, P192
[7]  
SINGERSAM J, 1989, AMPLIFICATIONS, V3, P118
[8]  
TSUJI K, 1992, HISTOCOMPATIBILITY T
[9]  
VANROOD JJ, 1967, HISTOCOMPATIBILITY T, P451
[10]  
WETZSTEON PJ, 1992, HUM IMMUNOL, V34, P101